DK0918469T3 - Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitet - Google Patents

Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitet

Info

Publication number: DK0918469T3
Authority: DK; Denmark
Prior art keywords: beta; creatine; alanine; preparations; methods
Prior art date: 1996-08-12

Application number

DK97937786T

Other languages

English (en)

Inventor

Mark Dunnett

Original Assignee

Harris Roger C

Johannsson Kenny

Mark Dunnett

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-12

Filing date

1997-08-12

Publication date

2003-02-10

1996-08-12 Priority claimed from GBGB9616910.7A external-priority patent/GB9616910D0/en

1997-08-12 Application filed by Harris Roger C, Johannsson Kenny, Mark Dunnett filed Critical Harris Roger C

2003-02-10 Application granted granted Critical

2003-02-10 Publication of DK0918469T3 publication Critical patent/DK0918469T3/da

Links

238000000034 method Methods 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title 1
UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 abstract 10
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 abstract 10
229940000635 beta-alanine Drugs 0.000 abstract 5
229960003624 creatine Drugs 0.000 abstract 5
239000006046 creatine Substances 0.000 abstract 5
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 4
238000009825 accumulation Methods 0.000 abstract 2
229960002885 histidine Drugs 0.000 abstract 2
210000002381 plasma Anatomy 0.000 abstract 2
230000036470 plasma concentration Effects 0.000 abstract 2
108010087806 Carnosine Proteins 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
230000037406 food intake Effects 0.000 abstract 1
238000001802 infusion Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1
210000001519 tissue Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Polymers & Plastics (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
Hematology (AREA)
Mycology (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Husbandry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Materials For Medical Uses (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK97937786T 1996-08-12 1997-08-12 Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitet DK0918469T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9616910.7A GB9616910D0 (en)	1996-08-12	1996-08-12	A method of increasing ›-alanylihistidine pipetide synthesis and accumulation in humans and animals
GBGB9621914.2A GB9621914D0 (en)	1996-08-12	1996-10-21	A method to simultaneously increase ›-alanylhistidine dipeptides and creatine in bodily tissues of humans and animals
PCT/IB1997/001117 WO1998006278A1 (en)	1996-08-12	1997-08-12	Methods and compositions for increasing the anaerobic working capacity in tissues

Publications (1)

Publication Number	Publication Date
DK0918469T3 true DK0918469T3 (da)	2003-02-10

Family

ID=26309862

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97937786T DK0918469T3 (da)	1996-08-12	1997-08-12	Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitet

Country Status (9)

Country	Link
EP (1)	EP0918469B1 (da)
JP (1)	JP4439019B2 (da)
CN (1)	CN1268234C (da)
AT (1)	ATE208144T1 (da)
AU (1)	AU4029397A (da)
CA (1)	CA2263184C (da)
DE (1)	DE69708109T2 (da)
DK (1)	DK0918469T3 (da)
WO (1)	WO1998006278A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5965596A (en)	1997-08-12	1999-10-12	Harris; Roger	Methods and compositions for increasing the anaerobic working capacity in tissue
US7504376B2 (en)	1996-08-12	2009-03-17	Natural Alternatives International	Methods and compositions for increasing the anaerobic working capacity in tissues
JPH11322617A (ja) *	1998-05-07	1999-11-24	Tokiwa Yakuhin Kogyo Kk	チキンまたはカキ抽出物を含有する胃潰瘍予防用または治療用の医薬組成物
EP1051914A1 (de) *	1999-05-08	2000-11-15	DSM Fine Chemicals Austria GmbH	Verwendung von Kreatin als Futterzusatz
JP4873778B2 (ja) *	2000-12-04	2012-02-08	焼津水産化学工業株式会社	抗疲労剤
US6855727B2 (en)	2000-12-04	2005-02-15	Yaizu Suisankagaku Industry Co., Ltd.	Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
JP2010150263A (ja) *	2003-04-10	2010-07-08	Natural Alternatives Internatl	組織における無酸素性作業能力を高めるための方法及び組成物
CA2621365C (en) *	2005-05-23	2012-09-04	Natural Alternatives International	Compositions and methods for the sustained release of beta-alanine
RU2335021C2 (ru) *	2006-10-06	2008-09-27	Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава	Способ повышения уровня работоспособности у лабораторных животных в эксперименте
CN105963299B (zh) *	2016-04-25	2018-09-18	南京农业大学	一种渔用糖代谢调控物及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS54159393A (en) *	1978-06-08	1979-12-17	Ajinomoto Co Inc	Polyamino acid-coated activated carbon
JPS6016934A (ja) *	1983-07-06	1985-01-28	Kaneshiro Nagai	抗腫瘍剤
WO1990006102A1 (en) *	1988-09-28	1990-06-14	Peptide Technology Limited	Compound and method for the retardation of collagen cross-linking
JPH0395125A (ja) *	1989-05-23	1991-04-19	Otsuka Pharmaceut Co Ltd	カルシウム代謝改善剤
IT1240336B (it) *	1990-03-21	1993-12-07	Setra	Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
JP2873493B2 (ja) *	1990-08-09	1999-03-24	理化学研究所	血糖調節剤
JP2873497B2 (ja) *	1990-09-03	1999-03-24	理化学研究所	脂質代謝調節剤
JPH0624976A (ja) *	1992-07-10	1994-02-01	Rikagaku Kenkyusho	輸液用組成物

1997
- 1997-08-12 AU AU40293/97A patent/AU4029397A/en not_active Abandoned
- 1997-08-12 CN CNB971986029A patent/CN1268234C/zh not_active Expired - Lifetime
- 1997-08-12 AT AT97937786T patent/ATE208144T1/de active
- 1997-08-12 CA CA002263184A patent/CA2263184C/en not_active Expired - Lifetime
- 1997-08-12 JP JP50954698A patent/JP4439019B2/ja not_active Expired - Lifetime
- 1997-08-12 DK DK97937786T patent/DK0918469T3/da active
- 1997-08-12 EP EP97937786A patent/EP0918469B1/en not_active Expired - Lifetime
- 1997-08-12 DE DE69708109T patent/DE69708109T2/de not_active Expired - Lifetime
- 1997-08-12 WO PCT/IB1997/001117 patent/WO1998006278A1/en not_active Ceased

Also Published As

Publication number	Publication date
DE69708109T2 (de)	2002-08-01
EP0918469B1 (en)	2001-11-07
CA2263184C (en)	2008-06-03
JP2000516464A (ja)	2000-12-12
CN1268234C (zh)	2006-08-09
EP0918469A1 (en)	1999-06-02
ATE208144T1 (de)	2001-11-15
WO1998006278A1 (en)	1998-02-19
JP4439019B2 (ja)	2010-03-24
CN1237881A (zh)	1999-12-08
CA2263184A1 (en)	1998-02-19
AU4029397A (en)	1998-03-06
DE69708109D1 (de)	2001-12-13

Publication	Publication Date	Title
DE60121027D1 (de)	2006-08-03	Lösung zur evaluierung und konservierung
BG60102B2 (bg)	1993-10-29	Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
BG106825A (en)	2003-02-28	Substituted oxazolidinones and their use in the field of blood coagulation
EA200001154A1 (ru)	2001-06-25	Твердые композиции, содержащие производные гамма-аминомасляной кислоты, и способ их получения
WO2003061768A3 (fr)	2004-03-11	Utilisation d'un compose inactivant la proteine kinase a dans une composition contenant un milieu cosmetiquement acceptable, pour eclaircir la peau
DK233586D0 (da)	1986-05-20	5-substituerede 1,3-thiazolidon-2,4-dion-forbindelser og farmaceutiske praeparater indeholdende disse
HUP9700567A1 (hu)	1998-06-29	Hatóanyagként dikambát és kinolinil-oxi-alkánsav-származékot tartalmazó herbicid kombináció és eljárás alkalmazására
DK0902789T3 (da)	2002-05-06	Androstenderivater
DE60137635D1 (de)	2009-03-26	Verwendung von allopurinol zur behandlung von bluthochdruck
DE69116380D1 (de)	1996-02-22	Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
NZ507203A (en)	2003-03-28	Use of dexmedetomidine for ICU sedation
EA200100791A1 (ru)	2002-04-25	Ингибиторы аминотрансфераз, зависимых от аминокислот с разветвленной цепью, и их применение в лечении диабетической ретинопатии
AU4029397A (en)	1998-03-06	Methods and compositions for increasing the anaerobic working capacity in tissues
ES2137125A1 (es)	1999-12-01	La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
BG60101B2 (bg)	1993-10-29	Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
CA2394938A1 (en)	2001-06-28	Glyoxalase i for reducing carbonyl compounds in carbonyl stress
PL339073A1 (en)	2000-12-04	Derivatives of benzoxazine and benzothiazine and their application in therapeutic agents
ES2166816T3 (es)	2002-05-01	Derivados piridil-imidazolicos y procedimientos para su preparacion.
GEP20043231B (en)	2004-05-25	Resorcinol Composition
EP0761214A3 (en)	1999-06-09	N,N-disubstituted anilines or alkylamines as singlet oxygen quenchers, topical compositions comprising them
RU96102110A (ru)	1998-05-10	Способ профилактики и лечения изъязвлений роговицы
TR200202103T2 (tr)	2002-11-21	''5-[{6-(2-Flüorobenzil)oksi-2-naftil}metil]-2,4-tiyazolidin dion kristalleri''
LU90993I2 (fr)	2003-02-18	Xigris-drotrécogine alfa(activée) et ses dérivés pharmaceutiquement acceptables
DE69734349D1 (de)	2006-02-23	Behandlung von knochenleiden mit adrenomedullin
KR100348888B1 (en)	2002-08-14	Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof